Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Scholten

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
The American Journal of Pathology|June 28, 2011
Migration of fibrocytes in fibrogenic liver injuryDavid Scholten, Donna Reichart, Yong Han Paik, et al.
Fibrogenesis & Tissue Repair|November 27, 2013
Experimental liver fibrosis research: update on animal models, legal issues and translational aspectsChristian Liedtke, Tom Luedde, Tilman Sauerbruch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 24, 2017
Endoglin in human liver disease and murine models of liver fibrosis-A protective factor against liver fibrosisMuhammad Alsamman, Viktor Sterzer, Steffen K Meurer, et al.
Plos One|February 26, 2013
Overexpression of endoglin modulates TGF-β1-signalling pathways in a novel immortalized mouse hepatic stellate cell lineSteffen K Meurer, Muhammad Alsamman, Hacer Sahin, et al.
Plos One|February 2, 2013
Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsisChristoph Roderburg, Mark Luedde, David Vargas Cardenas, et al.
Fibrogenesis & Tissue Repair|December 25, 2012
Origin of myofibroblasts in liver fibrosisDavid A Brenner, Tatiana Kisseleva, David Scholten, et al.
Scientific Reports|April 15, 2022
Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2Sebastian Bertram, Arturo Blazquez-Navarro, Maximilian Seidel, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2012
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosisTatiana Kisseleva, Min Cong, Yonghan Paik, et al.
Journal of Hepatology|December 15, 2007
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infectionHermann E Wasmuth, Mirko Moreno Zaldivar, Marie-Luise Berres, et al.
Gastroenterology|June 13, 2012
Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in miceFanli Meng, Kai Wang, Tomonori Aoyama, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
The American Journal of Pathology|June 28, 2011
Migration of fibrocytes in fibrogenic liver injuryDavid Scholten, Donna Reichart, Yong Han Paik, et al.
Fibrogenesis & Tissue Repair|November 27, 2013
Experimental liver fibrosis research: update on animal models, legal issues and translational aspectsChristian Liedtke, Tom Luedde, Tilman Sauerbruch, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 24, 2017
Endoglin in human liver disease and murine models of liver fibrosis-A protective factor against liver fibrosisMuhammad Alsamman, Viktor Sterzer, Steffen K Meurer, et al.
Plos One|February 26, 2013
Overexpression of endoglin modulates TGF-β1-signalling pathways in a novel immortalized mouse hepatic stellate cell lineSteffen K Meurer, Muhammad Alsamman, Hacer Sahin, et al.
Plos One|February 2, 2013
Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsisChristoph Roderburg, Mark Luedde, David Vargas Cardenas, et al.
Fibrogenesis & Tissue Repair|December 25, 2012
Origin of myofibroblasts in liver fibrosisDavid A Brenner, Tatiana Kisseleva, David Scholten, et al.
Scientific Reports|April 15, 2022
Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2Sebastian Bertram, Arturo Blazquez-Navarro, Maximilian Seidel, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 9, 2012
Myofibroblasts revert to an inactive phenotype during regression of liver fibrosisTatiana Kisseleva, Min Cong, Yonghan Paik, et al.
Journal of Hepatology|December 15, 2007
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infectionHermann E Wasmuth, Mirko Moreno Zaldivar, Marie-Luise Berres, et al.
Gastroenterology|June 13, 2012
Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in miceFanli Meng, Kai Wang, Tomonori Aoyama, et al.
Pageof 4